The Institute of Cancer and Crisis/LinkedIn
Oct 12, 2024, 10:34
The Institute of Cancer and Crisis – Ensuring the availability of essential radioisotopes for theranostics
The Institute of Cancer and Crisis (ICC) shared a post on Linkedin:
” Radiotherapy remains a vital cancer treatment, but global access is limited, especially in low- and middle-income countries. With over 50% of patients in these regions needing radiotherapy, there’s an urgent need for global investment and standards to improve access and outcomes.
This includes developing better infrastructure, aligning healthcare resources with patient needs, and ensuring the availability of essential radioisotopes for theranostics.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 07:59
Aug 8, 2025, 05:47
Aug 8, 2025, 05:01